insights_auto
Why is ARX up 7,14%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
0,52 AUD
arrow_upward
+7,14%(+0,035) 1D
30-сен., 16:10:13 GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
0,50 AUD
High
0,52 AUD
Low
0,48 AUD
Mkt. cap
181,60 млн
Avg. vol.
128,12 миң
Volume
590,47 миң
P/E ratio
50,68
52-wk high
0,80 AUD
52-wk low
0,48 AUD
EPS
0,01 AUD
Shares outstanding
345,90 млн
No. of employees
261
Open
0,50 AUD
High
0,52 AUD
Low
0,48 AUD
Mkt. cap
181,60 млн
Avg. vol.
128,12 миң
Volume
590,47 миң
P/E ratio
50,68
52-wk high
0,80 AUD
52-wk low
0,48 AUD
EPS
0,01 AUD
Shares outstanding
345,90 млн
No. of employees
261
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd